Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects

  title={Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects},
  author={Jonathan Kaplan and Lewis R. Mandel and Richard C. Stillman and Robert W. Walker and William J. A. Vandenheuvel and J. Christian Gillin and Richard Jed Wyatt},
Psychoactive doses (0.7 mg/kg) of the hallucinogen N,N-dimethyltryptamine (DMT) were administered intramuscularly to 11 normal subjects. A gas chromatographic-mass spectrometric isotope dilution determination of DMT concentrations in whole blood and urine revealed that only a fraction of the injected dose was recovered and the blood DMT concentrations had a very similar time course o the subjectively reported “high”. 

Figures, Tables, and Topics from this paper

Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects
The hallucinogenic substance N′,N′-dimethyltryptamine and its precursor N-methylryptamine were found in 24-h speciments of urine from 19 normal human subjects and the urinary excretion of both compounds was unrelated to age, sex, urinary volume, or creatinine, nor was any consistent diurnal pattern observed. Expand
Neuropharmacology of N,N-dimethyltryptamine
DMT appears to have limited neurotoxicity and other adverse effects except for intense cardiovascular effects when administered intravenously in large doses, and may be a useful experimental tool in exploring how the brain works and a useful clinical tool for treatment of anxiety and psychosis. Expand
eview europharmacology of N , N-dimethyltryptamine heresa
N,N-dimethyltryptamine (DMT) is an indole alkaloid widely found in plants and animals. It is best known for producing brief and intense psychedelic effects when ingested. Increasing evidence suggestsExpand
N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
  • S. Barker
  • Biology, Medicine
  • Front. Neurosci.
  • 2018
This report provides a historical overview of research concerning the endogenous hallucinogen N, N-dimethyltryptamine (DMT), focusing on data regarding its biosynthesis and metabolism in the brainExpand
Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
The present results show the existence in humans of alternative metabolic routes for DMT other than biotransformation by MAO and that O-demethylation plus conjugation is an important but probably not the only metabolic route for the harmala alkaloids in humans. Expand
Dimethyltryptamine: Endogenous Role and Therapeutic Potential
While the role of endogenous DMT remains unclear, ayahuasca has promising results in anxiety, depression and substance dependence, and it is crucial to conduct further research aimed at developing new treatments for psychiatric disorders. Expand
The hallucinogenic world of tryptamines: an updated review
A comprehensive update on tryptamine hallucinogens, concerning their historical background, prevalence, patterns of use and legal status, chemistry, toxicokinetics, toxicodynamics and their physiological and toxicological effects on animals and humans is provided. Expand
Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).
The synthesis of DMT is covered, as well as its pharmacology, metabolism, adverse effects, and potential use in medicine. Expand
Chapter 15 – Tryptamines
Tryptamines are a diverse group of 5HT2A agonist compounds. The predominant clinical effect produced by tryptamine exposure is hallucinations, mediated by agonism at 5HT2A and 5HT1A receptors.Expand
Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases.
A possible alternative metabolic pathway for DMT involving peroxidases that has not previously been described in humans is described and DMT and metabolites in a melanoma cell line are identified. Expand


Comparison of a placebo, N-dimethyltryptamine, and 6-hydroxy-N-dimethyltryptamine in man
DMT produced markedly significant mental effects including anxiety, hallucinations, and perceptual distortions and autonomic changes consisting of pupillary dilatation, increase in systolic and diastolic blood pressure, and a decrease in the kneejerk threshold. Expand
Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients
A gas chromatographic-mass spectrometric determination of the plasma N,N-dimethyltryptamine concentration from normals and psychiatric patients revealed that within the limit of sensitivity of theExpand
Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
Increases of urinary bufotenin and other N-methylated indoleamines were observed about two weeks before the mental and behavioural symptoms of the schizophrenic patients worsened, and these elevated levels continued during the period of behavioural exacerbations. Expand
Indole(ethyl)amine N-methyltransferase in human brain.
Preliminary evidence gathered in laboratories from rats infused intraventricularly with bufotenin has suggested that this substance is at least as potent as its powerfully hallucinogenic 5-methoxy congener, and may not easily cross the blood-brain barrier. Expand
Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma.
An isotope dilution assay for the determination of N,N-dimethyltryptamine in human plasma has been developed and serves as an internal standard in a gas chromatographic-mass spectrometric analysis of the final isolate. Expand
Psychotomimetic N-Methylated Tryptamines: Formation in Brain in vivo and in vitro
An enzyme that converts tryptamine and N-methyl-tryptamine to N- methyl-and dimethyltryptamine was found to be present in rat and human brain. Expand
Tryptamine, N,N-Dimethyltryptamine, N,N-Dimethyl-5-hydroxytryptamine and 5-Methoxytryptamine in Human Blood and Urine
5-Methoxytryptamine has been found in the urine of patients with rheumatic fever, and that in an order of magnitude of 30–210 µg/24 h, while N,N-dimethyl-5-hydroxytryptamine was still not demonstrated in blood. Expand
A dimethyltryptamine-forming enzyme in human blood.
An enzyme capable of forming the hallucinogen dimethyltryptamine was found in human red blood cells, plasma, and platelets and was higher in psychotic subjects than in nonpsychotics and was apparently related to the presence of a dialyzable inhibitor in the normal subjects. Expand
Identification of N,N-dimethyltryptamine as the product of an in vitro enzymic methylation.
Abstract Thin-layer chromatography, reverse isotope dilution assay, and combined gas-liquid chromatography-mass spectrometry have demonstrated that an enzyme obtained from human lung catalyzes the inExpand
Dimethyltryptamin: Its metabolism in man; the relation of its psychotic effect to the serotonin metabolism
Es wird festgestellt, dass Dimethyltryptamin — bei normalen Versuchspersonen — eine dem Meskalin und dem LSD-25 ähnliche psychotische Wirkung hat. Der durch Dimethyltryptamin induzierte ZustandExpand